Statins and lipoprotein(a); facing the residual risk

Gal Tsaban

doi:10.1093/eurjpc/zwab178

Statins and lipoprotein(a); facing the residual risk

Gal Tsaban

Department of Epidemiology, Biostatistics and Community Health Sciences

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	777-778
Number of pages	2
Journal	European Journal of Preventive Cardiology
Volume	29
Issue number	5
DOIs	https://doi.org/10.1093/eurjpc/zwab178
State	Published - 1 Mar 2022

ASJC Scopus subject areas

Epidemiology
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/eurjpc/zwab178

Cite this

@article{5442a8b5921443c7a8164d945e0403b8,

title = "Statins and lipoprotein(a); facing the residual risk",

author = "Gal Tsaban",

year = "2022",

month = mar,

day = "1",

doi = "10.1093/eurjpc/zwab178",

language = "English",

volume = "29",

pages = "777--778",

journal = "European Journal of Preventive Cardiology",

issn = "2047-4873",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Statins and lipoprotein(a); facing the residual risk

AU - Tsaban, Gal

PY - 2022/3/1

Y1 - 2022/3/1

UR - http://www.scopus.com/inward/record.url?scp=85129998325&partnerID=8YFLogxK

U2 - 10.1093/eurjpc/zwab178

DO - 10.1093/eurjpc/zwab178

M3 - Editorial

C2 - 34904162

AN - SCOPUS:85129998325

SN - 2047-4873

VL - 29

SP - 777

EP - 778

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

IS - 5

ER -

Statins and lipoprotein(a); facing the residual risk

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this